Automated immunoassay analyzer PATHFAST™
for clinical diagnosticmultiplexingmagnetic bead-based

Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 2
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 3
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 4
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 5
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 6
Automated immunoassay analyzer - PATHFAST™ - PHC Europe - for clinical diagnostic / multiplexing / magnetic bead-based - image - 7
Add to favorites
Compare this product

Characteristics

Operation
automated
Applications
for clinical diagnostic
Technology
magnetic bead-based, multiplexing
Analysis mode
chemiluminescence immunoassay, enzymatic chemiluminescence
Sample type
serum, plasma, whole blood, sputum
Tested parameter
D-dimer, cTnI, myoglobin, CRP, BNP, creatine kinase, hCG, PCT
Sampling mode
short turnaround time
Configuration
benchtop, compact
Other characteristics
with touch screen, with LIS connectivity, USB, with barcode reader, point-of-care
Sample volume

0.1 ml
(0.003381 US fl oz)

Number of tests

6 unit

Description

Product overview
PATHFAST™ is a compact desktop chemiluminescence enzyme immunoassay (CLEIA) analyzer combining CLEIA and Magtration® magnetic particle technology to deliver laboratory-correlated quantitative results from whole blood, plasma, serum and LAM extract/sputum for TB LAM Ag. It is intended for point-of-care and near-patient testing in hospitals, clinics and laboratories.

Key advantages
  • All-in-one single-use reagent cartridges: no additional reagents required
  • Flexible throughput: up to 6 samples or parameters per run via 6 parallel channels
  • Fast turnaround: typically <17 minutes for 6 samples for critical care, sepsis or TB LAM Ag assays
  • Supports whole blood, plasma, serum (and LAM extract / sputum for TB LAM Ag)
  • Compact desktop footprint suitable for point-of-care environments

Workflow
Three-step sample-to-result workflow: load sample into cartridge, place cartridge rack into the analyzer, start the assay; results are available rapidly to support clinical decision-making at the point of care.

Design and usability
  • 8.4-inch LCD touchscreen for intuitive operation
  • Wide-opening front door for easy cartridge rack access
  • Integrated barcode scanner and built-in printer
  • USB port for data transfer and maintenance hatch for service access
  • Three-color 360° status indicator for enhanced visibility in busy clinical settings

Principle & precision
Combines chemiluminescence enzyme immunoassay (CLEIA) with Magtration® magnetic particle processing to achieve accurate, precise results from small sample volumes and reproducible correlation with laboratory methods.

Available biomarkers & applications
Broad test menu for emergency care, critical care, sepsis diagnostics and tuberculosis, enabling rapid differential diagnosis:
  • Emergency care: hs‑cTnI (high-sensitivity troponin), Myoglobin (Myo), CK‑MB mass, D‑Dimer, NT‑proBNP, hsCRP, HCG-Preg
  • Sepsis: Presepsin, B.R.A.H.M.S PCT
  • Tuberculosis: TB LAM Ag (LAM extract / sputum workflow)

Operational monitoring & data
  • Integrated PC and touch-screen display with integrated printer
  • Patient, QC and calibration data storage (patient: 1000; QC: 1800; CAL: 300)
  • Data transfer: ASTM and fixed standard; RS-232C interface; USB for export

Notes
Test availability varies by country and regulatory approvals. PATHFAST™ must be operated according to the supplied operator instructions and local regulatory requirements.

Technical specifications
  • External dimensions: W320 × D586 × H524 mm
  • Weight: 32 kg
  • Instrument type: Desktop immunoassay analyzer
  • Throughput: Up to 6 samples or parameters per run
  • Measuring time: <17 minutes for 6 samples (typical for TB LAM Ag, critical care or sepsis markers)
  • Sampling material: LAM extract, whole blood, plasma, serum
  • Measuring principle: CLEIA + Magtration® magnetic particle technology
  • Reaction temperature: 37 °C
  • Sample volume: 100 µL
  • Data storage capacity: Patient 1000; QC 1800; CAL 300
  • Data transfer: ASTM and fixed standard; RS-232C; USB
  • Electrical requirements: 100–240 V AC (50/60 Hz)
  • Power consumption: 360 VA
  • Display: 8.4-inch LCD touchscreen; integrated printer and PC
  • Calibration: Factory calibration; 2-point calibration every 4 weeks
  • Recommended operation: 24-h stand-by capability
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.
About MedicalExpo
MedicalExpo is a marketplace that offers B2B players a complete experience, from product sourcing to purchase. MedicalExpo is an entity of VirtualExpo Group.